Speaking with CNBC’s Brian Sullivan, Oxford Vaccine Group Co-Director Adrian Hill says the Covid-19 vaccine he is helping to develop with AstraZeneca is “more than likely” to work and expects to have millions of doses ready by the end of…
Speaking with CNBC’s Brian Sullivan, Oxford Vaccine Group Co-Director Adrian Hill says the Covid-19 vaccine he is helping to develop with AstraZeneca is “more than likely” to work and expects to have millions of doses ready by the end of…
A potential coronavirus vaccine developed by Oxford University in the U.K. has produced a strong immune response in a large, early-stage human trial, according to newly-released data published Monday in the medical journal, The Lancet. CNBC’s Meg Tirrell reports. Subscribe…
NBC News’ Erika Edwards shares the stories of coronavirus patients who thought they had recovered from the coronavirus but are testing positive again just weeks later, raising questions about how long COVID-19 antibodies last. » Subscribe to NBC News: »…